|
Quotes & Info
|
| INO > SEC Filings for INO > Form 8-K on 23-Sep-2008 | All Recent SEC Filings |
23-Sep-2008
Other Events, Financial Statements and Exhibits
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced on September 23, 2008 via press release, attached to this report as Exhibit 99.1 and hereby incorporated by reference, that it has received a contract for $933,000 from the Department of Defense (US Army) to continue research and development of DNA-based vaccines delivered via its proprietary electroporation system.
(d) Exhibits
99.1 Press Release dated September 23, 2008
|
|